Title:
ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2
Document Type and Number:
WIPO Patent Application WO/2024/006287
Kind Code:
A3
Abstract:
Disclosed herein are compound of Formula I, Formula II, or Formula III: or a pharmaceutically acceptable salt and/or solvate of any one or more thereof, pharmaceutical compositions including such compounds, and methods of treating disease by administering or contacting a subject with one or more of the above compounds.
Inventors:
WANG JINGXIN (US)
TANG ZHICHAO (US)
TANG ZHICHAO (US)
Application Number:
PCT/US2023/026356
Publication Date:
February 15, 2024
Filing Date:
June 27, 2023
Export Citation:
Assignee:
UNIV KANSAS (US)
International Classes:
A61K31/395; A61K31/445; A61K31/496; A61K31/505; A61K31/33
Domestic Patent References:
| WO2015095449A1 | 2015-06-25 | |||
| WO2012170546A1 | 2012-12-13 | |||
| WO2016073947A1 | 2016-05-12 |
Foreign References:
| US20200291011A1 | 2020-09-17 |
Other References:
DATABASE PUBCHEM COMPOUND ANONYMOUS : "3-Phenyl-7-piperazin-1-ylchromen-2-one", XP093141699, retrieved from PUBCHEM
WOLL ET AL.: "Discovery and Optimiization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy", JOURNAL OF MEDICINAL CHEMISTRY, vol. 59, no. 13, 14 June 2016 (2016-06-14), pages 6070 - 6085, XP055700661, DOI: 10.1021/acs.jmedchem.6b00460
WOLL ET AL.: "Discovery and Optimiization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy", JOURNAL OF MEDICINAL CHEMISTRY, vol. 59, no. 13, 14 June 2016 (2016-06-14), pages 6070 - 6085, XP055700661, DOI: 10.1021/acs.jmedchem.6b00460
Attorney, Agent or Firm:
MCPARLAND, James P. et al. (US)
Download PDF: